The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cells

Citation
R. Zeidler et al., The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cells, BR J CANC, 83(2), 2000, pp. 261-266
Citations number
29
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
BRITISH JOURNAL OF CANCER
ISSN journal
00070920 → ACNP
Volume
83
Issue
2
Year of publication
2000
Pages
261 - 266
Database
ISI
SICI code
0007-0920(200007)83:2<261:TFOANC>2.0.ZU;2-S
Abstract
Bispecific antibodies (bsAb) are considered as promising tools for the elim ination of disseminated tumour cells in a minimal residual disease situatio n. The bsAb-mediated recruitment of an immune effector cell in close vicini ty of a tumour cell is thought to induce an antitumoural immune response. H owever, classical bispecific molecules activate only a single class of immu ne effector cell that may not yield optimal immune responses. We therefore constructed an intact bispecific antibody, BiUII (anti-CDS x anti-EpCAM), t hat not only recognizes tumour cells and T lymphocytes with its two binding arms, but also binds and activates Fc gamma-receptor positive accessory ce lls through its Fc-region. We have demonstrated recently that activated acc essory cells contribute to the bsAb-induced antitumoural activity. We now a nalyse this stimulation in more detail and demonstrate here the BiUII-induc ed upregulation of activation markers like CD83 and CD95 on accessory cells and the induction of neopterin and biopterin synthesis. Experiments with p ure cell subpopulations revealed binding of BiUII to CD64+ accessory cells and CD16+ NK cells, but not to CD32+ B lymphocytes. We provide further evid ence for the importance of the Fc-region in that this bispecific molecule s timulates Fc gamma-R-positive accessory cells to eliminate tumour cells in vitro by direct phagocytosis. (C) 2000 Cancer Research Campaign.